Cargando…

Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients

BACKGROUND: Minimally invasive vertebral augmentation procedures are widely used to treat vertebral compression fractures although procedural polymethylmethacrylate cement leakage remains common. We report herein our initial experience with a novel vertebral augmentation technique designed to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Korovessis, Panagiotis, Repantis, Thomas, Miller, Larry E, Block, Jon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189204/
https://www.ncbi.nlm.nih.gov/pubmed/21939548
http://dx.doi.org/10.1186/1471-2474-12-206
_version_ 1782213448503918592
author Korovessis, Panagiotis
Repantis, Thomas
Miller, Larry E
Block, Jon E
author_facet Korovessis, Panagiotis
Repantis, Thomas
Miller, Larry E
Block, Jon E
author_sort Korovessis, Panagiotis
collection PubMed
description BACKGROUND: Minimally invasive vertebral augmentation procedures are widely used to treat vertebral compression fractures although procedural polymethylmethacrylate cement leakage remains common. We report herein our initial experience with a novel vertebral augmentation technique designed to treat symptomatic vertebral osteoporotic fractures and osteolytic metastases with minimal cement extravasation. METHODS: Forty-two vertebral fractures were identified in 26 consecutive patients (mean age 74 ± 9 years). All patients were treated with a novel percutaneous vertebral augmentation device (Kiva(® )VCF Treatment System, Benvenue Medical, Santa Clara, CA, USA). Indications for surgery included recent (≤ 3 months) symptomatic osteoporotic vertebral fracture (n = 34) and pathologic vertebral fractures (e.g. metabolic bone disease, myeloma, metastasis) (n = 8) located between T10 and S1. Patient outcomes were evaluated pre-treatment and at 2- and 6-month follow-up visits. Postoperative cement extravasation was assessed with computed tomography. Patient-reported back pain was quantified using an 11-point numeric scale. Back-specific functional disability was self-reported with the Oswestry Disability Index on a 0 to 100% scale. RESULTS: No cases of intraoperative hypotension, respiratory disturbance, neurological deterioration, infection, or death were observed. There were 2 (4.8%) levels where anterior cement leakage was visible radiographically in patients with osteolyses. No intracanal leakage was observed. Back pain scores improved 71% (p < 0.001) from pre-treatment to the 6-month follow-up. Back function improved 56% from baseline to 6 months (p < 0.001). CONCLUSIONS: The initial clinical experience with the Kiva(® )System demonstrated significant improvements in back pain and function with minimal and clinically insignificant procedural cement leakage.
format Online
Article
Text
id pubmed-3189204
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31892042011-10-08 Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients Korovessis, Panagiotis Repantis, Thomas Miller, Larry E Block, Jon E BMC Musculoskelet Disord Research Article BACKGROUND: Minimally invasive vertebral augmentation procedures are widely used to treat vertebral compression fractures although procedural polymethylmethacrylate cement leakage remains common. We report herein our initial experience with a novel vertebral augmentation technique designed to treat symptomatic vertebral osteoporotic fractures and osteolytic metastases with minimal cement extravasation. METHODS: Forty-two vertebral fractures were identified in 26 consecutive patients (mean age 74 ± 9 years). All patients were treated with a novel percutaneous vertebral augmentation device (Kiva(® )VCF Treatment System, Benvenue Medical, Santa Clara, CA, USA). Indications for surgery included recent (≤ 3 months) symptomatic osteoporotic vertebral fracture (n = 34) and pathologic vertebral fractures (e.g. metabolic bone disease, myeloma, metastasis) (n = 8) located between T10 and S1. Patient outcomes were evaluated pre-treatment and at 2- and 6-month follow-up visits. Postoperative cement extravasation was assessed with computed tomography. Patient-reported back pain was quantified using an 11-point numeric scale. Back-specific functional disability was self-reported with the Oswestry Disability Index on a 0 to 100% scale. RESULTS: No cases of intraoperative hypotension, respiratory disturbance, neurological deterioration, infection, or death were observed. There were 2 (4.8%) levels where anterior cement leakage was visible radiographically in patients with osteolyses. No intracanal leakage was observed. Back pain scores improved 71% (p < 0.001) from pre-treatment to the 6-month follow-up. Back function improved 56% from baseline to 6 months (p < 0.001). CONCLUSIONS: The initial clinical experience with the Kiva(® )System demonstrated significant improvements in back pain and function with minimal and clinically insignificant procedural cement leakage. BioMed Central 2011-09-22 /pmc/articles/PMC3189204/ /pubmed/21939548 http://dx.doi.org/10.1186/1471-2474-12-206 Text en Copyright ©2011 Korovessis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Korovessis, Panagiotis
Repantis, Thomas
Miller, Larry E
Block, Jon E
Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients
title Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients
title_full Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients
title_fullStr Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients
title_full_unstemmed Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients
title_short Initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: A case series of 26 consecutive patients
title_sort initial clinical experience with a novel vertebral augmentation system for treatment of symptomatic vertebral compression fractures: a case series of 26 consecutive patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189204/
https://www.ncbi.nlm.nih.gov/pubmed/21939548
http://dx.doi.org/10.1186/1471-2474-12-206
work_keys_str_mv AT korovessispanagiotis initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients
AT repantisthomas initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients
AT millerlarrye initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients
AT blockjone initialclinicalexperiencewithanovelvertebralaugmentationsystemfortreatmentofsymptomaticvertebralcompressionfracturesacaseseriesof26consecutivepatients